Approval · Notice of Compliance 1908 · 1999
MELACINE: Notice of Compliance 1908
Issued November 4, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1908
- Date
- November 4, 1999
- Company
- Corixa CorporationSeattle, Washington, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Immunostimulating agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MELACINE | 02241211 | Cancelled Post Market |
Medicinal ingredients
- MELANOMA LYSATE 20,000,000 CELLS per VIAL